BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18339683)

  • 1. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling.
    Lamy S; Beaulieu E; Labbé D; Bédard V; Moghrabi A; Barrette S; Gingras D; Béliveau R
    Carcinogenesis; 2008 May; 29(5):1033-41. PubMed ID: 18339683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation.
    Lamy S; Blanchette M; Michaud-Levesque J; Lafleur R; Durocher Y; Moghrabi A; Barrette S; Gingras D; Béliveau R
    Carcinogenesis; 2006 May; 27(5):989-96. PubMed ID: 16308314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
    Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
    J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound.
    Labrecque L; Lamy S; Chapus A; Mihoubi S; Durocher Y; Cass B; Bojanowski MW; Gingras D; Béliveau R
    Carcinogenesis; 2005 Apr; 26(4):821-6. PubMed ID: 15661805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dietary flavones apigenin and luteolin impair smooth muscle cell migration and VEGF expression through inhibition of PDGFR-beta phosphorylation.
    Lamy S; Bédard V; Labbé D; Sartelet H; Barthomeuf C; Gingras D; Béliveau R
    Cancer Prev Res (Phila); 2008 Nov; 1(6):452-9. PubMed ID: 19138992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the novel selective platelet-derived growth factor receptor antagonist CT52923 on cellular proliferation, migration, and suppression of neointima following vascular injury.
    Yu JC; Lokker NA; Hollenbach S; Apatira M; Li J; Betz A; Sedlock D; Oda S; Nomoto Y; Matsuno K; Ide S; Tsukuda E; Giese NA
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1172-8. PubMed ID: 11504817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDGF-BB increases endothelial migration on cord movements during angiogenesis in vitro.
    Thommen R; Humar R; Misevic G; Pepper MS; Hahn AW; John M; Battegay EJ
    J Cell Biochem; 1997 Mar; 64(3):403-13. PubMed ID: 9057098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors.
    Sun J; Wang DA; Jain RK; Carie A; Paquette S; Ennis E; Blaskovich MA; Baldini L; Coppola D; Hamilton AD; Sebti SM
    Oncogene; 2005 Jul; 24(29):4701-9. PubMed ID: 15897913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
    Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
    Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migratory and proliferative effect of platelet-derived growth factor in rabbit retinal endothelial cells: evidence of an autocrine pathway of platelet-derived growth factor.
    Koyama N; Watanabe S; Tezuka M; Morisaki N; Saito Y; Yoshida S
    J Cell Physiol; 1994 Jan; 158(1):1-6. PubMed ID: 7505273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lycopene inhibits PDGF-BB-induced signaling and migration in human dermal fibroblasts through interaction with PDGF-BB.
    Chiang HS; Wu WB; Fang JY; Chen DF; Chen BH; Huang CC; Chen YT; Hung CF
    Life Sci; 2007 Nov; 81(21-22):1509-17. PubMed ID: 17950366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis.
    Kappert K; Sparwel J; Sandin A; Seiler A; Siebolts U; Leppänen O; Rosenkranz S; Ostman A
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2644-51. PubMed ID: 16990553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling.
    Kano MR; Morishita Y; Iwata C; Iwasaka S; Watabe T; Ouchi Y; Miyazono K; Miyazawa K
    J Cell Sci; 2005 Aug; 118(Pt 16):3759-68. PubMed ID: 16105884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
    Bran B; Bran G; Hörmann K; Riedel F
    Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation.
    Sparwel J; Vantler M; Caglayan E; Kappert K; Fries JW; Dietrich H; Böhm M; Erdmann E; Rosenkranz S
    Cardiovasc Res; 2009 Mar; 81(4):758-70. PubMed ID: 19074160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice.
    Pontén A; Folestad EB; Pietras K; Eriksson U
    Circ Res; 2005 Nov; 97(10):1036-45. PubMed ID: 16224065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular frontiers without borders: multifaceted roles of platelet-derived growth factor (PDGF) in supporting postnatal angiogenesis and lymphangiogenesis.
    Vincent L; Rafii S
    Cancer Cell; 2004 Oct; 6(4):307-9. PubMed ID: 15488752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2.
    Park JS; Kim MH; Chang HJ; Kim KM; Kim SM; Shin BA; Ahn BW; Jung YD
    Int J Oncol; 2006 Nov; 29(5):1247-52. PubMed ID: 17016658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury.
    Hur KY; Seo HJ; Kang ES; Kim SH; Song S; Kim EH; Lim S; Choi C; Heo JH; Hwang KC; Ahn CW; Cha BS; Jung M; Lee HC
    Eur J Pharmacol; 2008 May; 586(1-3):226-33. PubMed ID: 18387604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.